Physicochemical characterization and stability of rifampicin liposome dry powder formulations for inhalation.

@article{Changsan2009PhysicochemicalCA,
  title={Physicochemical characterization and stability of rifampicin liposome dry powder formulations for inhalation.},
  author={N. Changsan and H. Chan and F. Separovic and T. Srichana},
  journal={Journal of pharmaceutical sciences},
  year={2009},
  volume={98 2},
  pages={
          628-39
        }
}
Liposomes were used to encapsulate rifampicin (RIF) as an alternative formulation for delivery to the respiratory tract. Factors affecting the stability of liposomes containing RIF were determined. Four liposome suspensions were prepared, containing different millimole ratios of cholesterol (CH) and soybean L-infinity-phosphatidylcholine (SPC) by the chloroform film method, followed by freeze-drying. Cryo-transmission electron microscopy, photon correlation spectroscopy, (2)H and (31)P solid… Expand
Improving Topical Skin Delivery of Monocrotaline via Liposome Gel-based Nanosystems.
TLDR
Results of in vitro drug release showed that MCT in liposomal gels could be released in 12 h constantly in physiological saline as a Ritger-Peppas model. Expand
Storage stability of inhalable, controlled-release powder formulations of ciprofloxacin nanocrystal-containing liposomes.
TLDR
Dry powder inhalers of CNL were physiochemically stable in sucrose lyoprotectant when stored below 4 %RH at room temperature for six months. Expand
Dry powder inhalation formulation of chitosan nanoparticles for co-administration of isoniazid and pyrazinamide
TLDR
The dry powder formulations were not toxic to the respiratory tract cell lines and did not provoke alveolar macrophages into producing inflammatory cytokines or nitric oxides, indicating that the formulations are safe and could potentially be used to deliver to respiratory tract for tuberculosis treatment. Expand
Monitoring safety of liposomes containing rifampicin on respiratory cell lines and in vitro efficacy against Mycobacterium bovis in alveolar macrophages
TLDR
Rifampicin-encapsulated liposomes were evidently nontoxic to respiratory associated cells, including bronchial epithelial cells, small airway epithelial and alveolar macrophages, and did not activate AMs to produce interleukin-1β, tumor necrosis factor-α, and nitric oxide at a level that would cascade to other inflammatory effects. Expand
(Solvato-) Polymorphism of Formulations of Rifampicin for Pulmonary Drug Delivery Prepared Using a Crystallization/ Spray Drying Process.
TLDR
It was concluded that processes involving a recrystallization from EtOH and MeOH produce particles of a common isostructural group of channel solvates that form rifampicin dihydrate with suitable aerosol performance and stability. Expand
Recent advances in liposomal dry powder formulations: preparation and evaluation
Liposomal drug dry powder formulations have shown many promising features for pulmonary drug administration, such as selective localization of drug within the lung, controlled drug release, reducedExpand
Fabrication of polyelectrolyte multilayered vesicles as inhalable dry powder for lung administration of rifampicin.
TLDR
In vitro coated formulations had a strong ability to be easilyInternalized and to greatly prolong the residence time of their components in A549 cells compared to uncoated liposomes that were rapidly internalized and just as quickly removed. Expand
Physical properties of griseofulvin-lipid nanoparticles in suspension and their novel interaction mechanism with saccharide during freeze-drying.
TLDR
Powder X-ray diffraction revealed that xylose existed in the crystalline state in the freeze-dried nanoparticles, whereas the other saccharides existed in amorphous states, and the crystallization of the saccharide was found to be strongly correlated with the aggregation property of the nanoparticles. Expand
Single step spray drying method to develop proliposomes for inhalation: a systematic study based on quality by design approach.
TLDR
The study results demonstrated the application of QbD principles and design of experiment (DOE) approach to develop drug encapsulated proliposomes for inhalation by spray drying in single step. Expand
Inhaled pyrazinamide proliposome for targeting alveolar macrophages
TLDR
PZA-proliposomes were less toxic to respiratory-associated cells, and did not activate AMs to produce inflammatory mediators, including interleukin-1β, tumor necrosis factor-α, and nitric oxide, at a toxic level, suggesting that PZA- Proliposome are potential candidates for pulmonary tuberculosis treatment. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 30 REFERENCES
Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages.
TLDR
The results suggest that the ligand-anchored liposomal aerosols are not only effective in rapid attainment of high-drug concentration in lung with high population of alveolar macrophages but also maintain the same over prolonged period of time. Expand
Liposomes for drug delivery to the lungs by nebulization.
TLDR
Results of NE% and NER% for Rif-loaded liposomes show that DSPC/Chol (2:1) is the best composition for RIF delivery in vesicular form to lungs, by nebulization, however if mucoadhesion is required, improvement may be needed. Expand
Molecular and physicochemical aspects of the interactions of the tuberculostatics ofloxacin and rifampicin with liposomal bilayers: a 31P-NMR and DSC study
Abstract ζ-Potential measurements were obtained in order to determine whether electrostatic interactions occur between the tuberculostatics ofloxacin and rifampicin and the molecular species ofExpand
Lung specific stealth liposomes: stability, biodistribution and toxicity of liposomal antitubercular drugs in mice.
TLDR
In vivo stability of these liposomes demonstrated the slow and controlled release of their encapsulated contents and encapsulated drugs also demonstrated reduced in vivo toxicity in comparison to free drug(s). Expand
Interaction of rifampicin and isoniazid with large unilamellar liposomes: spectroscopic location studies.
TLDR
Steady-state fluorescence intensity and fluorescence energy transfer studies between rifampicin and a set of functionalized probes reveal that, in both systems, isoniazid is located at the membrane surface whereas rifampsicin is deeply buried inside the lipid bilayers. Expand
Preparation and characterization of liposomes as therapeutic delivery systems: a review.
TLDR
Issues and challenges involved in prolonging the shelf-life of liposomes is presented and the importance of complete removal of organic solvent that is used in the process is covered. Expand
Effect of Freezing Rate on the Stability of Liposomes During Freeze-Drying and Rehydration
TLDR
Analysis by DSC of dipalmitoylphosphatidylcholine and DPPC liposome dispersions showed that the freezing protocol affected the bilayer melting characteristics of these liposomes after freeze-drying and rehydration. Expand
Stability of dry liposomes in sugar glasses.
TLDR
Solute leakage from dry liposomes was extremely slow at temperatures below the glass transition temperature (Tg); however, it increased exponentially as temperature increased to near or above the Tg, indicating that the glassy state had to be maintained for dryliposomes to retain trapped solutes. Expand
Application of spectrofluorometry for evaluation of dry powder inhalers in vitro.
TLDR
Spectrofluorometry can be used as a substitute method to HPLC-UV in determining the small quantity of salbutamol after aerosolization from dry powder aerosols and is suggested to be a rapid and efficient method in the pharmaceutical analysis of aerosols. Expand
Therapeutic efficacies of isoniazid and rifampin encapsulated in lung-specific stealth liposomes against Mycobacterium tuberculosis infection induced in mice
TLDR
Liposomal drugs at and below therapeutic concentrations were more effective than free drugs against tuberculosis, as evaluated on the basis of CFUs detected, organomegaly, and histopathology. Expand
...
1
2
3
...